118 related articles for article (PubMed ID: 37163002)
1. Unveiling the Domain-Specific and RAS Isoform-Specific Details of BRAF Regulation.
Trebino T; Markusic B; Nan H; Banerjee S; Wang Z
bioRxiv; 2023 Sep; ():. PubMed ID: 37163002
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation.
Trebino TE; Markusic B; Nan H; Banerjee S; Wang Z
Elife; 2023 Dec; 12():. PubMed ID: 38150000
[TBL] [Abstract][Full Text] [Related]
3. RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation.
Spencer-Smith R; Terrell EM; Insinna C; Agamasu C; Wagner ME; Ritt DA; Stauffer J; Stephen AG; Morrison DK
Mol Cell; 2022 Nov; 82(22):4262-4276.e5. PubMed ID: 36347258
[TBL] [Abstract][Full Text] [Related]
4. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
[TBL] [Abstract][Full Text] [Related]
5. A novel phosphorylation site involved in dissociating RAF kinase from the scaffolding protein 14-3-3 and disrupting RAF dimerization.
Yu A; Nguyen DH; Nguyen TJ; Wang Z
J Biol Chem; 2023 Oct; 299(10):105188. PubMed ID: 37625591
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding.
Martinez Fiesco JA; Durrant DE; Morrison DK; Zhang P
Nat Commun; 2022 Jan; 13(1):486. PubMed ID: 35078985
[TBL] [Abstract][Full Text] [Related]
7. Analyses of the oncogenic BRAF
Cope NJ; Novak B; Liu Z; Cavallo M; Gunderwala AY; Connolly M; Wang Z
J Biol Chem; 2020 Feb; 295(8):2407-2420. PubMed ID: 31929109
[TBL] [Abstract][Full Text] [Related]
8. Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
Park E; Rawson S; Li K; Kim BW; Ficarro SB; Pino GG; Sharif H; Marto JA; Jeon H; Eck MJ
Nature; 2019 Nov; 575(7783):545-550. PubMed ID: 31581174
[TBL] [Abstract][Full Text] [Related]
9. The RAS-Binding Domain of Human BRAF Protein Serine/Threonine Kinase Exhibits Allosteric Conformational Changes upon Binding HRAS.
Aramini JM; Vorobiev SM; Tuberty LM; Janjua H; Campbell ET; Seetharaman J; Su M; Huang YJ; Acton TB; Xiao R; Tong L; Montelione GT
Structure; 2015 Aug; 23(8):1382-1393. PubMed ID: 26165597
[TBL] [Abstract][Full Text] [Related]
10. An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation.
Heard JJ; Phung I; Potes MI; Tamanoi F
BMC Cancer; 2018 Jan; 18(1):69. PubMed ID: 29320991
[TBL] [Abstract][Full Text] [Related]
11. B-Raf autoinhibition in the presence and absence of 14-3-3.
Zhang M; Jang H; Li Z; Sacks DB; Nussinov R
Structure; 2021 Jul; 29(7):768-777.e2. PubMed ID: 33711246
[TBL] [Abstract][Full Text] [Related]
12. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK
Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534
[TBL] [Abstract][Full Text] [Related]
13. MEK drives BRAF activation through allosteric control of KSR proteins.
Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains.
Weinberg F; Griffin R; Fröhlich M; Heining C; Braun S; Spohr C; Iconomou M; Hollek V; Röring M; Horak P; Kreutzfeldt S; Warsow G; Hutter B; Uhrig S; Neumann O; Reuss D; Heiland DH; von Kalle C; Weichert W; Stenzinger A; Brors B; Glimm H; Fröhling S; Brummer T
Oncogene; 2020 Jan; 39(4):814-832. PubMed ID: 31558800
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma.
Dumaz N
Small GTPases; 2011 Sep; 2(5):289-292. PubMed ID: 22292133
[TBL] [Abstract][Full Text] [Related]
16. Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.
Travers T; López CA; Agamasu C; Hettige JJ; Messing S; García AE; Stephen AG; Gnanakaran S
Biophys J; 2020 Aug; 119(3):525-538. PubMed ID: 32649863
[TBL] [Abstract][Full Text] [Related]
17. Regulation of RAF family kinases: new insights from recent structural and biochemical studies.
Spencer-Smith R; Morrison DK
Biochem Soc Trans; 2024 Jun; 52(3):1061-1069. PubMed ID: 38695730
[TBL] [Abstract][Full Text] [Related]
18. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.
Wang P; Jia X; Lu B; Huang H; Liu J; Liu X; Wu Q; Hu Y; Li P; Wei H; Liu T; Zhao D; Zhang L; Tian X; Jiang Y; Qiao Y; Nie W; Ma X; Bai R; Peng C; Dong Z; Liu K
Signal Transduct Target Ther; 2023 Mar; 8(1):96. PubMed ID: 36872366
[TBL] [Abstract][Full Text] [Related]
19. RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers.
Nichols RJ; Haderk F; Stahlhut C; Schulze CJ; Hemmati G; Wildes D; Tzitzilonis C; Mordec K; Marquez A; Romero J; Hsieh T; Zaman A; Olivas V; McCoach C; Blakely CM; Wang Z; Kiss G; Koltun ES; Gill AL; Singh M; Goldsmith MA; Smith JAM; Bivona TG
Nat Cell Biol; 2018 Sep; 20(9):1064-1073. PubMed ID: 30104724
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and inhibition of BRAF kinase.
Gunderwala A; Cope N; Wang Z
Curr Opin Chem Biol; 2022 Dec; 71():102205. PubMed ID: 36067564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
